Currently, out of the existing stock ratings of Whit Mayo - 123 which are a Buy (54.42%), 95 which are a Hold (42.04%), 8 which are a Sell (3.54%)

Whit Mayo

Work Performance Price Targets & Ratings Chart

Analyst Whit Mayo works at LEERINK and is covering Healthcare, Financial Services sectors with 417 price targets and ratings displayed on 26 stocks. Previously, Whit Mayo worked at UBS, BAIRD.

Whit Mayo's average stock forecast success ratio is 68.18% with an average time for price targets to be met of 160.48 days.

Most recent stock forecast was given on UNH, UnitedHealth Group at 14-Jun-2023.

Wall Street Analyst Whit Mayo

Analyst best performing recommendations are on CLOV (CLOVER HEALTH INVESTMENTS).
The best stock recommendation documented was for CLOV (CLOVER HEALTH INVESTMENTS) at 11/8/2022. The price target of $1.5 was fulfilled within 3 days with a profit of $0.21 (16.28%) receiving and performance score of 54.26.

Average potential price target upside

of $95.48 (23.46%) on UNH (UNITEDHEALTH GROUP).
of $70.76 (17.84%) on HUM (HUMANA).
of $44.6 (25.7%) on HCA (HCA HEALTHCARE).

ACHC Acadia Healthcare Company AHCO AdaptHealth AMED Amedisys ANTM Anthem APR CI Cigna HCA HCA Healthcare HUM Humana THC Tenet Healthcare UNH UnitedHealth Group DVA DaVita LHCG LHC Group MD MEDNAX FMS Fresenius Medical Care AG . KGaA SGRY Surgery Partners AGL Agilon Health CLOV Clover Health Investments ONEM 1Life Healthcare OSH Oak Street Health PRVA Privia Health Group AIRS ELV UHS Universal Health Services BK The Bank of New York Mellon EHC Encompass Health MS

Show more stocks

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Joseph France (LOOP CAPITAL)